Delivery Order SPE2DB24D2003-SPE2DB24FXCS6
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The award has a potential value of $6,104.00 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is issued under a larger indefinite delivery contract...
- This is a $1,088.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML and has a completion date of May 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
- This is a $1,582.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The order has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,367.86, is for the provision of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of a specialty pharmaceutical product, MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The award, valued at $1,863.54, has an ultimate completion date of April 11, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $11,445.72 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp...
- This is a $7,131.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $1,250.28 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order is for MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a prescription medication, with a potential value of $2,643.54 and a completion date of February 27, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime...
- This is a $1,632.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB24FXCS6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of the medication MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a potential value of $34,008.51 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for providing this pharmaceutical product to DLA Troop Support Medical facilities in support of military treatment programs. This delivery order is issued under a larger indefinite delivery contract held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 2/15/24 |